Astellas Pharma Inc 2015 Integrated Report
The report presents Astellas' fiscal 2014 consolidated sales of ¥1,247.3 billion, actual global greenhouse gas emissions of 210 kilotons, and progress on global health initiatives. It highlights the Action on Fistula program, through which 416 Kenyan women with obstetric fistula had received reconstructive surgery by the end of its first year.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2015
Type: Integrated Report
Pages: 156
Back to company
Astellas Pharma Inc
Annual Report
The report presents Astellas' fiscal 2014 consolidated sales of ¥1,247.3 billion, actual global greenhouse gas emissions of 210 kilotons, and progress on global health initiatives. It highlights the Action on Fistula program, through which 416 Kenyan women with obstetric fistula had received reconstructive surgery by the end of its first year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Apr 1, 2014 - Mar 31, 2015
Fiscal Year
2014
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Women in Management
Employees